BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 10754991)

  • 21. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    ; Lager JJ; Lyden ER; Anderson JR; Pappo AS; Meyer WH; Breitfeld PP
    J Clin Oncol; 2006 Jul; 24(21):3415-22. PubMed ID: 16849756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soft tissue sarcomas arising in the retroperitoneal space in children. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
    Crist WM; Raney RB; Tefft M; Heyn R; Hays DM; Newton W; Beltangady M; Maurer HM
    Cancer; 1985 Oct; 56(8):2125-32. PubMed ID: 3896467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhabdomyosarcoma and soft tissue sarcoma in childhood.
    Womer RB; Pressey JG
    Curr Opin Oncol; 2000 Jul; 12(4):337-44. PubMed ID: 10888419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of radiation therapy in the treatment of soft tissue sarcomas of childhood.
    Dritschilo A; Weichselbaum R; Cassady JR; Jaffe N; Paed D; Green D; Filler RM
    Cancer; 1978 Sep; 42(3):1192-203. PubMed ID: 100208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology Group.
    Raney B; Anderson J; Arndt C; Crist W; Maurer H; Qualman S; Wharam M; Wiener E; Meyer W;
    Pediatr Blood Cancer; 2008 Sep; 51(3):339-43. PubMed ID: 18523987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Raney RB; Walterhouse DO; Meza JL; Andrassy RJ; Breneman JC; Crist WM; Maurer HM; Meyer WH; Parham DM; Anderson JR
    J Clin Oncol; 2011 Apr; 29(10):1312-8. PubMed ID: 21357783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
    Oberlin O; Rey A; Sanchez de Toledo J; Martelli H; Jenney ME; Scopinaro M; Bergeron C; Merks JH; Bouvet N; Ellershaw C; Kelsey A; Spooner D; Stevens MC
    J Clin Oncol; 2012 Jul; 30(20):2457-65. PubMed ID: 22665534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary intraspinal soft-tissue sarcoma in childhood: report of two cases with a review of the literature.
    Raney RB; Ater JL; Herman-Liu A; Leeds NE; Cleary KR; Womer RB; Rorke LM
    Med Pediatr Oncol; 1994; 23(4):359-64. PubMed ID: 8058008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soft tissue sarcoma of the perineal region in childhood. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1972 through 1984.
    Raney RB; Crist W; Hays D; Newton W; Ruymann F; Tefft M; Beltangady M
    Cancer; 1990 Jun; 65(12):2787-92. PubMed ID: 2187589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.
    Zhu S; Xu N; Zhi T; Gao Y; Zhong D; Zhang W; Jin M; Sun Q; Xie Y; Zhang X; Li L; Wang S; Wang H; Liu R; Zhao W; Huang D; Ni X; Ma X
    J Cancer Res Ther; 2023 Aug; 19(4):876-880. PubMed ID: 37675711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
    Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
    J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of 51 cases with rare childhood soft tissue sarcomas].
    Cai MX; Pan C; Ye QD; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):917-922. PubMed ID: 27938592
    [No Abstract]   [Full Text] [Related]  

  • 37. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
    Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
    J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Sandler E; Lyden E; Ruymann F; Maurer H; Wharam M; Parham D; Link M; Crist W
    Med Pediatr Oncol; 2001 Nov; 37(5):442-8. PubMed ID: 11745872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.
    Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH
    J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic adult-type non-rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group.
    Ferrari A; Orbach D; Casanova M; van Noesel MM; Berlanga P; Brennan B; Corradini N; Schoot RA; Ramirez-Villar GL; Hjalgrim LL; Alaggio R; Guillen Burrieza G; Safwat A; Cameron AL; van Rijn RR; Minard-Colin V; Zanetti I; Bisogno G; Chisholm JC; Merks JHM
    Cancer; 2023 Aug; 129(16):2542-2552. PubMed ID: 37084075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.